While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...

Companies have long used perceptual mapping to understand how consumers feel about their brands relative to competitors’, to find gaps in the marketplace, and to develop brand positions.

Duquesne Family Office's chief is cashing in his chips on two leading artificial intelligence (AI) stocks in favor of a ...

“This bipartisan legislation will promote generic drug competition and improve patient access to lower-cost medications,” said Senator Collins. “By reaffirming the so-called ‘skinny label’ pathway, ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

FDA approves Hikma Pharmaceuticals' generic version of Victoza, a once-daily GLP-1 injection for Type 2 diabetes. Other drugmakers also entering the market.

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...